Dipeptidyl aspartyl fluoromethylketones as potent caspase inhibitors: SAR of the N-protecting group
Authors:
- 1 November 2004
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 14 (21) , 5295-5300
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Dipeptidyl aspartyl fluoromethylketones as potent caspase-3 inhibitors: SAR of the P2 amino acidBioorganic & Medicinal Chemistry Letters, 2004
- Structure-Based design of nonpeptide inhibitors of interleukin-1β converting enzyme (ICE, Caspase-1)Bioorganic & Medicinal Chemistry, 2002
- Protection against TNF-Induced Liver Parenchymal Cell Apoptosis during Endotoxemia by a Novel Caspase Inhibitor in MiceToxicology and Applied Pharmacology, 2000
- Simplified Pepstatins: Synthesis and Evaluation of N-Terminally Modified AnaloguesJournal of Medicinal Chemistry, 1999
- Conformationally constrained inhibitors of caspase-1 (interleukin-1β converting enzyme) and of the human ced-3 homologue caspase-3 (CPP32, apopain)Bioorganic & Medicinal Chemistry Letters, 1998
- Peptidomimetic aminomethylene ketone inhibitors of interleukin-1β-converting enzyme (ICE)Bioorganic & Medicinal Chemistry Letters, 1998
- First Examples of Peptidomimetic Inhibitors of Interleukin-1β Converting EnzymeJournal of Medicinal Chemistry, 1996
- Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosisNature, 1995
- Structural and stereochemical requirements of time-dependent inactivators of the interleukin-1β converting enzymeBioorganic & Medicinal Chemistry Letters, 1995
- t-Butyl Esters of Amino Acids and Peptides and their Use in Peptide Synthesis1Journal of the American Chemical Society, 1960